Theoretically, CA was postulated to interfere with blood glucose levels and thus also possibly interfere with the existing hypoglycaemic therapy and cholesterol lowering agents[81]. A double-blind, placebo-controlled https://bookmarkhard.com/story17682203/ne-demek